991
Views
1
CrossRef citations to date
0
Altmetric
Articles

Fungistatic Activity of Kojic Acid Against Human Pathogenic Fungi and Inhibition of Melanin-production in Cryptococcus neoformans

&
Pages 248-250 | Received 12 Aug 2003, Published online: 22 Jun 2018

References

  • Cabanes, J., Chazara, S. and Garcia-Carmona, F. 1994. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase. J. Pharm. Pharmacol. 46: 982–985.
  • Doering, T. L., Nosanchuk, J. D., Roberts, W. K. and Casadevall, A. 1999. Melanin as a potential cryptococcal defense against microbicidal proteins. Medical Mycology 37: 175–179.
  • Jacobson, E. S. and Emery, H. S. 1991. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J. Bacteriol. 173: 401–403.
  • Niwa, Y and Akamatsu, H. 1991. Kojic acid scavengers free radicals while potentiating leucocyte function including free radical generation. Inflammation. 15: 303–315.
  • Rhodes, J. C., Polacheck, I. and Kwon-Chung, K. J. 1982. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect. Immun. 36: 1175–1184.
  • Rosfarizan, M., Ariff, A. B., Hassan, M. A. and Karim, M. I. A. 1998. Kojic acid production by Aspergillus flavus using gelatinized and hydrolyzed Sago starch as carbon sources. Folia Microbiologica. 98: 514–519.
  • Wang, Y. and Casadevall, A. 1994. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect. Immun. 64: 3004–3007.
  • Wheeler, M. H. and Bell, A. A. 1988. Melanins and their importance in pathogenic fungi. Curr. Top. Med. Mycol. 3: 338–387.
  • Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S. and Rahal, J. J. 1986. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann. Intern. Med. 104: 234–240.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.